Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (284 total)
-
Autor: Occupational Safety and Health Administration (OSHA)
Tema: Research
Tipo de elemento: Guía
Fecha de actualización: 2011
Descripción: This publication provides a general overview of a particular standards-related topic. This publication does not alter or determine compliance responsibilities which are set forth in OSHA standards, and the Occupational Safety and Health Act of 1970.… -
Autor: FDA
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2023-05-12
Descripción: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Autor: FDA
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-07-20
Descripción: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Autor: Boghuma K Titanji, Bryan Tegomoh, Saman Nematollahi, Michael Konomos, Prathit A Kulkarni
Tema: General
Tipo de elemento: Publicación
Fecha de actualización: 2022-06-23
Descripción: We present in this review an updated overview of monkeypox for healthcare professionals in the context of the ongoing outbreaks around the world. -
Autor: Hegde, S. T., H. Salje, H. M. S. Sazzad, M. J. Hossain, M. Rahman, P. Daszak, J. D. Klena, S. T. Nichol, S. P. Luby, and E. S. Gurley.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2019-08-01
Descripción: Understanding the true burden of emergent diseases is critical for assessing public-health impact. However, surveillance often relies on hospital systems that only capture a minority of cases. We use the example of Nipah-virus infection in… -
Autor: Playford, E. G., T. Munro, S. M. Mahler, S. Elliott, M. Gerometta, K. L. Hoger, M. L. Jones, P. Griffin, K. D. Lynch, H. Carroll, D. El Saadi, M. E. Gilmour, B. Hughes, K. Hughes, E. Huang, C. de Bakker, R. Klein, M. G. Scher, I. L. Smith, L. F.…
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-04
Descripción: The monoclonal antibody m102.4 is a potent, fully human antibody that neutralises Hendra and Nipah viruses in vitro and in vivo. We aimed to investigate the safety, tolerability, pharmacokinetics, and immunogenicity of m102.4 in healthy adults. -
Autor: Michael K. Lo, Friederike Feldmann, Joy M. Gary, Robert Jordan, Roy Bannister, Jacqueline Cronin, Nishi R. Patel, John D. Klena, Stuart T. Nichol, Tomas Cihlar, Sherif R. Zaki, Heinz Feldmann, Christina F. Spiropoulou, and Emmie de Wit.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2019-05-29
Descripción: Nipah virus is an emerging pathogen in the Paramyxoviridae family. Upon transmission of Nipah virus from its natural reservoir, Pteropus spp. fruit bats, to humans, it causes respiratory and neurological disease with a case-fatality rate about 70%. -
Autor: CITI Program
Tema: Laboratory
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022
Descripción: The Collaborative Institutional Training Initiative (CITI Program) is dedicated to serving the training needs of colleges and universities, healthcare institutions, technology and research organizations, and governmental agencies, as they foster… -
Autor: CDC
Tema: Laboratory
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-06-29
Descripción: This page includes a selection of different laboratory trainings. -
Autor: CDC
Tema: Laboratory
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-10-26
Descripción: CDC has more than 1700 scientists, working in more than 200 cutting-edge laboratories across the U.S. from Atlanta to Spokane, to Ft Collins, to Cincinnati, Pittsburgh, Morgantown, Anchorage, and San Juan. While CDC’s laboratories are diverse in…
